Table of Contents
1. Executive Summary
2. Market Background and Classifications
2.1:Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2014 to 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Nanobiotechnology Market Trends and Forecast
3.3: Global Nanobiotechnology Market by Application
3.3.1: Pharmaceuticals
3.3.2: Medical Devices
3.3.3: Medical Research
3.3.4: Others
3.4: Global Nanobiotechnology Market by Therapeutics
3.4.1: Dental Therapies
3.4.2: Cardiac Therapies
3.4.3: Orthopedic Therapies
3.4.4: Others
4.Market Trends and Forecast Analysis by Region
4.1: Global Nanobiotechnology Market by Region
4.2: North American Nanobiotechnology Market
4.2.1: Market by Application: Pharmaceuticals, Medical Devices, Medical Research, and Others
4.2.2: Market by Therapeutics: Dental Therapies, Cardiac Therapies, Orthopedic Therapies, and Others
4.2.3: Market by Species: Fish, Crustaceans, and Mollusks
4.2.4: The United States Nanobiotechnology Market
4.2.5: The Canadian Nanobiotechnology Market
4.2.6: The Mexican Nanobiotechnology Market
4.3: European Nanobiotechnology Market
4.3.1: Market by Application: Pharmaceuticals, Medical Devices, Medical Research, and Others
4.3.2: Market by Therapeutics: Dental Therapies, Cardiac Therapies, Orthopedic Therapies, and Others
4.3.3: The Nanobiotechnology Market of United Kingdom
4.3.4: The German Nanobiotechnology Market
4.3.5: The French Nanobiotechnology Market
4.4: APAC Nanobiotechnology Market
4.4.1: Market by Application: Pharmaceuticals, Medical Devices, Medical Research, and Others
4.4.2: Market by Therapeutics: Dental Therapies, Cardiac Therapies, Orthopedic Therapies, and Others
4.4.3: The Chinese Nanobiotechnology Market
4.4.4: The Indian Nanobiotechnology Market
4.4.5: The Japanese Nanobiotechnology Market
4.5: ROW Nanobiotechnology Market
4.5.1: Market by Application: Pharmaceuticals, Medical Devices, Medical Research, and Others
4.5.2: Market by Therapeutics: Dental Therapies, Cardiac Therapies, Orthopedic Therapies, and Others
4.5.3: Brazilian Nanobiotechnology Market
5. Competitor Analysis
5.1: Market Share Analysis
5.2: Product Portfolio Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. Cost Structure Analysis
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. Growth Opportunities and Strategic Analysis
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Nanobiotechnology Market by Application
7.1.2: Growth Opportunities for the Global Nanobiotechnology Market by Therapeutics
7.1.3: Growth Opportunities for the Global Nanobiotechnology Market by Region
7.2: Emerging Trends in the Global Nanobiotechnology Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Nanobiotechnology Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global NanobiotechnologyMarket
7.3.4: Certification and Licensing
8. Company Profiles of Leading Players
8.1: Aduro BioTech
8.2: Calando Pharmaceuticals Inc.
8.3: Biosante Phosphate Pharmaceuticals Inc..
8.4: Celgene Corporation
8.5: Elan Pharmaceuticals Inc.
8.6: Flamel Technologies Inc.
8.7: Nanophase Technologies Corporation
8.8: Sigma Aldrich Company
8.9: Dendritic Nanotechnologies Inc.
8.10: SkyePharma Pharmaceuticals